The MARVEL project
“Evolving reversible immunocapture by membrane sensing peptides: towards scalable extracellular vesicles isolation” – brings innovation to healthcare and especially to its diagnostic and therapeutic tools.
Find out more
news from EVengers
Report on the Second Regenerative medicine workshop
31.5.2023
This is the event report on the 2nd Regenerative Medicine workshop “From project to market” that took ...
MARVEL project workshop | 21 April 2023, Milan, Italy
21.4.2023
On 21 April 2023, we had an Extracellular Vesicles (EVs) dedicated workshop in Milan, Italy ...
MARVEL project – final
20.4.2023
On 20th April 2023, MARVEL project partners (SCITEC-CNR, ITM-CNR, Istituto Cardiocentro Ticino, UniSR Università Vita-Salute ...
FET-PROACT project MARVEL workshop
17.4.2023
REGISTRATION HAS FINISHED
Are you an industrial representative, researcher, or young investigator working in the expansive ...
Meet our partner – HansaBioMed Life Sciences
21.3.2023
MARVEL project consortium consists of 7 partners (CNR-SCITEC, CNR-ITM, Istituto Cardiocentro Ticino, Vita-Salute San Raffaele University, HansaBioMed ...